Malignant or accelerated hypertension in IgA nephropathy.

Area of Science:

• Nephrology
• Hypertension Research
• Renal Pathology

Background:

• Immunoglobulin A nephropathy (IgA nephropathy) is a common glomerular disease.
• Hypertension is a known complication and potential driver of IgA nephropathy progression.
• The association between IgA nephropathy and malignant hypertension in adults requires further elucidation.

Purpose of the Study:

• To determine the incidence of hypertension, particularly malignant hypertension, in adult patients diagnosed with IgA nephropathy.
• To investigate the clinical and histopathological characteristics of IgA nephropathy patients presenting with severe hypertension.
• To assess the renal outcomes in this patient cohort.

Main Methods:

• Retrospective analysis of 66 adult patients with biopsy-proven IgA nephropathy.
• Review of initial clinical presentation, including blood pressure and symptoms.
• Examination of renal biopsy histopathology, focusing on vascular changes.
• Tracking of patient outcomes, including progression to end-stage renal failure.

Main Results:

• 36% of patients were hypertensive at initial presentation.
• 15% of hypertensive patients had malignant or accelerated hypertension.
• Vascular findings included proliferative endarteritis, fibrinoid necrosis, arteriolosclerosis, and vascular hypertrophy.
• Six patients progressed to end-stage renal failure within 14 months, despite blood pressure control.

Conclusions:

• The incidence of malignant hypertension in adults with IgA nephropathy appears higher than previously reported.
• IgA nephropathy associated with malignant hypertension may lead to rapid renal failure.
• Further histopathologic studies are needed to confirm the true incidence and understand the pathogenesis of this association.